
OncoVista Innovative Therapies, Inc. OVIT
OVIT
OncoVista Innovative Therapies, Inc. IMUC
EOM Pharmaceuticals Holdings, Inc. NWBO
Northwest Biotherapeutics, Inc. CPRX
Catalyst Pharmaceuticals, Inc. ARNI
Arno Therapeutics, Inc. FPMI
FluoroPharma Medical, Inc. BZYR
Burzynski Research Institute, Inc. HSTC
HST Global, Inc. PFND
Pathfinder Cell Therapy, Inc.
OncoVista Innovative Therapies, Inc. IMUC
EOM Pharmaceuticals Holdings, Inc. NWBO
Northwest Biotherapeutics, Inc. CPRX
Catalyst Pharmaceuticals, Inc. ARNI
Arno Therapeutics, Inc. FPMI
FluoroPharma Medical, Inc. BZYR
Burzynski Research Institute, Inc. HSTC
HST Global, Inc. PFND
Pathfinder Cell Therapy, Inc.
Performance
Periode | OVIT | IMUC | NWBO | CPRX | ARNI | FPMI | BZYR | HSTC | PFND |
---|---|---|---|---|---|---|---|---|---|
6M | 0.00 % | -39.60 % | 10.35 % | -10.53 % | 0.00 % | 0.00 % | -21.90 % | -99.98 % | 0.00 % |
YTD | -50.00 % | -46.75 % | -14.53 % | -5.20 % | 0.00 % | 0.00 % | 13.36 % | -99.98 % | 0.00 % |
1Y | 0.00 % | -23.08 % | -18.01 % | -1.16 % | -66.67 % | 0.00 % | -2.38 % | -99.98 % | 0.00 % |
3Y | 0.00 % | -87.67 % | -65.21 % | 62.55 % | 9 900.00 % | -97.83 % | 21.18 % | -99.86 % | 0.00 % |
5Y | -99.73 % | -80.85 % | -77.88 % | 539.50 % | -93.75 % | -95.45 % | -9.89 % | -99.79 % | -96.95 % |
10Y | -99.96 % | -80.85 % | -95.91 % | 553.85 % | -99.98 % | -99.97 % | -56.07 % | -99.37 % | -98.75 % |
Depuis le début | -99.99 % | -80.85 % | -99.98 % | 234.43 % | -100.00 % | -99.99 % | -71.89 % | -100.00 % | -99.97 % |